for Sep 14, 2020
Question for the randomized controlled trial nazis that have proliferated since COVID:
— Covid19Crusher (@Covid19Crusher) September 14, 2020
what percentage of the guidelines of the Infectious Diseases Society of America are based on RCTs?
The answer is 14% according to the study below.
Medicine is not RCTs.https://t.co/do9G5J3Flm pic.twitter.com/CNWmvsAiLt
NEW 🔥🔥#CID
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
Clinical Experience of Implementing Oral Versus Intravenous Antibiotics (OVIVA) in a Specialist Orthopedic Hospital.
Real world practice #IDTwitter https://t.co/e55eCTiX9f pic.twitter.com/JoRUnJ8Kse
The lasting misery of #coronavirus long-haulers https://t.co/cTMc8q7t7S the disease is so new so “to assess long-term consequences, the only thing you need is time.”
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
Drug treatments for covid-19: living systematic review and network meta-analysis | @bmj_company 35 trials with 16,588 patients included. Glucocorticoids “probably” ⬇️ mortality; RDV “probably” ⬇️ duration of symptoms; HCQ has no effect in ether. https://t.co/03R5Y4eJRA
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
Interactions b/w influenza A virus and bacterial species of the upper respiratory tract promotes the stability and infectivity of IAV during desiccation stress and suggests a potential role for these respiratory communities in IAV transmission. @mSystemsJ https://t.co/fzWcYb0qGt pic.twitter.com/Dzq2tS7ofH
— ASM (@ASMicrobiology) September 14, 2020
Why we need to temper our expectations about a vaccine - and please get your flu shot
— Zain Chagla (@zchagla) September 14, 2020
With @TorontoIDDoc @BogochIsaac https://t.co/FKJwlUy43g
Now that we've evidence of efficacy of non-medical masks, it's worth asking whether adding their broader use to other measures could drop Rt back below 1 in BC and ON. Here's some strong early work from @DFisman https://t.co/bC4RDvnnJ1
— David Patrick (@DavidPatrickMD) September 14, 2020
NEW 🔥 #ACC @ASMicrobiology @TheIDApprentice
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
Avibactam restored aztreonam susceptibility in 98% of aztreonam-resistant Stenotrophomonas maltophilia isolates,compared to 61%, 71%, and 15% with clavulanate,relebactam& vaborbactam,respectively #IDTwitter https://t.co/NMBtOTy1fR
The S. aureus ATP synthase is an important factor in influencing the immune response during biofilm-associated infection and bacterial persistence. @mBioJournal https://t.co/TXPGJV5iEe pic.twitter.com/kz1ILnHhLO
— ASM (@ASMicrobiology) September 14, 2020
@WHO and @AfricaCDC has announced @acegid as one of the three reference laboratories for the storage and analysis of the genomes of infectious diseases in Africa. https://t.co/3LybU2z70B pic.twitter.com/wZeRUIhRaj
— ACEGID (@acegid) September 14, 2020
The ID community grieves the loss of Dr. Rebecca Shadowen, who passed away on Sept. 11 after a four-month long battle with COVID-19. Dr. Shadowen's work as a frontline hero will forever be remembered. #WeAreID https://t.co/53RcTwqGwE
— IDSA (@IDSAInfo) September 14, 2020
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, will speak via video at @GovPhilScott's press briefing tomorrow. He'll also take questions https://t.co/mtmP4FzZOq pic.twitter.com/tSP5bi406T
— Seven Days (@sevendaysvt) September 14, 2020
Another labor of love trying to take a crack at these pesky MBLs. Big shout out to @PrecisionAbxLab
— Eric Wenzler (@TheIDApprentice) September 14, 2020
and @jmilabs for the collab and expertise on the WGS and RT-PCR. Check it out! @Notorious_ID https://t.co/VwTt8YERmY
#Publication📑:This study analyzes the pathways through which #tree-based farm & #landscape change affect #food & #nutrition security, the spread of infectious #disease, prevalence of non-communicable diseases & human migration in Sub-Saharan #Africa.
— World Agroforestry (@ICRAF) September 14, 2020
▶️ https://t.co/ZEEPfabrY1 pic.twitter.com/fQYcHcJmie
Fewer Americans trust top U.S. health officials — such as the CDC and Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases — than earlier in the pandemic, according to a new poll from the Kaiser Family Foundation. https://t.co/xXtTct7P7H pic.twitter.com/OI0GB2AATX
— WebMD (@WebMD) September 14, 2020
Management of Gram-negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact with and without Antibiotic Stewardship | Open Forum Infectious Diseases | Oxford Academic https://t.co/tkhH42ToUQ
— José Miguel Arancibia H. 🦠 (@pollistico77) September 14, 2020
The latest run of Antimicrobial Stewardship in #Veterinary Practice course starts today - sign up now! Learn from experts and study alongside a global community at your own pace.#VetAMShttps://t.co/mCQXWjVIuD pic.twitter.com/oLvHBKCjlu
— BSAC (@BSACandJAC) September 14, 2020
🔥Breaking news🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
RECOVERY COVID-19 phase 3 trial to evaluate @Regeneron REGN-COV2 investigational antibody cocktail in the UK. #Recoverytrial will be the 4th late-stage RCT evaluating REGN-COV2.
Repurposed ➡️ Designed drugshttps://t.co/mRq7gI571i
Beyond antibiotics: harnessing bacteria’s natural predators https://t.co/XJANE24VsO
— Antibiotic Action (@TheUrgentNeed) September 14, 2020
MEDITECH's Antimicrobial Stewardship Toolkit consists of advanced clinical decision support and real-time surveillance. https://t.co/N4RmndoHfh #SepsisAwarenessMonth #SAM2020 #sepsis pic.twitter.com/tqvDUCU6XH
— MEDITECH (@MEDITECH) September 14, 2020
Coronavirus: Monoclonal antibodies to begin UK trial https://t.co/ftfnUA1yQ6
— Laura Piddock (@LauraPiddock) September 14, 2020
Billionaire Ramon Ang’s RSA Foundation will be building a hospital in Southern Luzon, which would also serve as a research hub for infectious diseases. https://t.co/Qhm5wXZCwa
— Rappler (@rapplerdotcom) September 14, 2020
Evotec and the French-based @BIOASTER Technological Research Institute today announced that they have entered into a partnership to advance research for infectious diseases | #researchneverstops #antimicrobialresistance #AMR | Press release https://t.co/IrXgzTy1Zx pic.twitter.com/dmpfJfFa9N
— Evotec (@Evotec) September 14, 2020
The #Vancomycin AUC debate continues...Check out our letter with @jacksonjstew & twitterless Bruce Daltonhttps://t.co/DLUzhlmBN8 pic.twitter.com/X6CelUwMRP
— Sarah Jorgensen 🌈🎶🇨🇦 (@canuckIDpharm) September 14, 2020
#Antibiotics essential for treatment of sepsis.#Babies and #cancer patients are two groups that are particularly at risk of #sepsis. Sepsis may afflict patients with #Covid_19. Learn more. 👇🏾👇🏿👇🏽#WorldSepsisDay #SepsisAwarenessMonth @uicc @Cancerfonden https://t.co/fFLD4XAtoD
— ReAct Action on ABR (@reactgroup) September 14, 2020
Catalonia has documented four cases of Covid-19 reinfection, with one patient in the ICU at the Germans Trias i Mújol Hospital in Barcelona province. That’s according to the head of Infectious Diseases at the hospital, who has spoken to radio station RAC1 https://t.co/B9TaFCdRjC
— El País English Edition (@elpaisinenglish) September 14, 2020
Neisseria gonorrhoeae gentamicin AST methodology must be standardized and interpretive criteria established to optimize the monitoring of susceptibility trends. #JACNews #EditorsChoice https://t.co/nKcpTVknY2
— BSAC (@BSACandJAC) September 14, 2020
Marking World Sepsis Day #WorldSepsisDay at Our Lady's Hospital, Navan. Staff busy providing Hand Hygiene training, Antimicrobial Stewardship updates and Blood Culture technique training #recognisesepsis @ceconroy @IEHospitalGroup pic.twitter.com/bvwV4NXyPI
— annejones (@annejon24065844) September 14, 2020
.@IbukunMD congratulations! The SHEA #NICU series has been so great to work on... Trying to address some knowledge gaps.
— JB Cantey, MD, MPH (@InfectiousNeo) September 14, 2020
SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Staphylococcus aureus disease prevention https://t.co/NKs51KSVqW
For the second day of #pharmacyawareness we are tackling #antimicrobialstewardship check out @NZAPSOtago insta account throughout today for more posts and quizzes! https://t.co/BDs1h2r3JJ
— Jared Davidson (@jaredda96) September 14, 2020
Missed 'The social science of #infectiousdiseases'? Tune into the podcast to hear @BroomAlex @kennykatherine @sarah_bernays @AssaDoron @rnzadoks @carlatreloar & Nadine Ehlers discuss the complex relationship between microbes, animals, humans & societies. https://t.co/7pKr7Jjmvg
— SSPS (@Usyd_ssps) September 14, 2020
NSW records just one locally acquired case of COVID-19.
— Peter Collignon (@CollignonPeter) September 14, 2020
However, as testing numbers drop, NSW Health has warned the virus is most likely still circulating undetected in the community. https://t.co/AHNQwNmNAp
Group B streptococcus drug resistance in pregnant women in Iran: a meta-analysis. https://t.co/3hIF2E5kX9
— AntibioticResistance (@AntibioticResis) September 14, 2020
Microbiology Monday: Inside the light organ, V. fischeri transitions into a symbiotic, sessile state where the quorum-signaling regulator LitR induces luminescence. LitR expression and luminescence are repressed by HbtR in seawater. @mBioJournal https://t.co/wduuxCJQjR pic.twitter.com/Xni2kFjIvG
— ASM (@ASMicrobiology) September 14, 2020
This is Scary!!
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
Lung scans from a 50-year-old show that damage from COVID-19 (red) can improve with time — but many patients have lasting symptoms. #COVID19 long-haulers
Post-acute covid-19 #longcovid https://t.co/bQfqf2Vj0X pic.twitter.com/SLZRmFuQ0B
🔥Breaking news🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 14, 2020
Press Release
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with #COVID19 in @NIAIDNews Sponsored ACTT-2 Trial
One-day reduction in median recovery TIME 😯 https://t.co/gq91Lxow6I
COVID-19 isn't the only infectious disease scientists are trying to find a vaccine for. Here are 3 others https://t.co/bIYOfqlZVt via @ConversationEDU Nice article about other diseases they are trying to develop vaccines against.
— Professor Adrian Esterman (@profesterman) September 14, 2020
Should We Mandate a COVID-19 Vaccine for Children? | Infectious Diseases | JAMA Pediatrics | JAMA Network https://t.co/dfQfxoes41
— xavier sáez-llorens (@xsaezll) September 14, 2020
🗣️📢: @GareyKgarey & colleagues are looking for PhDs/PharmDs/MDs interested in #AMR research for their Texas Med Ctr Training Program in Antimicrobial Resistance. Check it out! https://t.co/KxpBCKpsZY
— Julie Ann Justo (@julie_justo) September 14, 2020
I can personally attest to @GareyKgarey's amazingly supportive mentorship 😉
https://t.co/WKLKjKIvyu The COVID vaccine can't come soon enough, though we should set our expectations on what this vaccine can/will do. @zchagla @BogochIsaac and share some thoughts with @globeandmail
— Sumon Chakrabarti (@TorontoIDDoc) September 14, 2020
STEWARDSHIP / RESISTANCE SCAN: Rapid diagnostics for bloodstream infections; Oral antibiotics for bone-joint infections; Antibiotic overuse after dischargehttps://t.co/0kBSQ5HHXR #AMR #AntibioticStewardship #Diagnostics
— CIDRAP (@CIDRAP) September 14, 2020
This 👇 is excellent: Schools, grandparents and coronavirus @jackiecassell https://t.co/s2DUUzHUWm
— Laura Piddock (@LauraPiddock) September 14, 2020
Symbiotics combine prebiotics & probiotics to synergistically enhance health benefits. This study establishes a high-throughput screen for prebiotic substrate utilization by individual strains which can be used for synbiotic matchmaking @AppEnvMicro https://t.co/bFZBQ5dlK8 pic.twitter.com/BsHYGcsSc9
— ASM (@ASMicrobiology) September 14, 2020
👏🏼👏🏼 Congratulations to my friend @RSPugliese for getting into CID and for such a cool topic!!!
— Bug Pharmacist 💊🧫 Tim Gauthier (@IDstewardship) September 14, 2020
📲 https://t.co/DwCNoomtyk #3Dprinting #DesignHealth pic.twitter.com/zhWB4SpIeE
Amid spotty response, COVID silently stalked US for weeks -- Inadequate monitoring and tracking allowed the virus to spread unchecked, 2 genomic studies suggest #COVID19https://t.co/IK6hA8mIKz pic.twitter.com/OTLSksIzPq
— CIDRAP (@CIDRAP) September 14, 2020
"La PCR te dice si tienes o no tienes relación con el virus; lo que interpretemos y decidamos a partir de esa información ya es cosa nuestra” vía @aberronhttps://t.co/oVikke6YJ3
— Javier Casas Ciria #UsaMascarilla (@cientounero) September 14, 2020
30 million Americans are infected with a brain parasite spread by cats & contaminated meat, #Toxoplasma gondii, but most will never show symptoms.
— Microbes&Infection (@MicrobesInfect) September 14, 2020
The parasite is kept in check by microglia which release IL-1α.https://t.co/X0xaPcLv42
"Just because you’ve been studying infectious diseases for 40 years doesn’t mean you can tell me I need to wear a mask for a disease my friend from junior high says is a hoax." https://t.co/TvTcekkZt6
— SF Examiner (@sfexaminer) September 14, 2020
Exciting to hear that the combination of RDV and Baricitinab in ACTT-2 had a positive outcome with reduction in time to recovery in hospitalized patients with #COVID19 https://t.co/VcdAauxlFm
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
Don’t miss @TheLancet journals’ session details & related content for #ECCVID. Sign up for Lancet Conference Alerts | Infectious Diseases today: https://t.co/OE3NkXp6DS
— The Lancet Infectious Diseases (@TheLancetInfDis) September 14, 2020
The world waits as scientists race to develop a vaccine for #COVID. Prof Johnson Mak and Dr Danielle Stanisic @DanielleStanis2 from @GlycoGriffith look at other infectious diseases that scientists are working to find a vaccine for @ConversationEDU: https://t.co/NZeLZN1yO9
— Griffith University (@Griffith_Uni) September 14, 2020
As the #COVID-19 crisis continues to develop, #researchers around the world are attempting to find the most effective #treatment to #combat the poorly understood virus behind this #disease 💪
— SwissCognitive (@SwissCognitive) September 14, 2020
https://t.co/0SXKDePVLN
McMaster ID Fellow Research Group with @DocDominik publication #2 in AAC: Novel antibiotics may be non-inferior, but are they becoming less effective? A systematic review https://t.co/nsRFZclK7x
— Anthony Bai (@tonybai16) September 14, 2020
This is the answer to COVID & maybe many other infectious diseases caused by viruses that fullfil 3 of the 4 Koch’s postulates.
— TurtlePoker (@TurtlePoker) September 14, 2020
Not a toxic vaccine
University Of Pittsburgh Scientists Discover Biomolecule That May Neutralize Coronavirus – CBS Pittsburgh https://t.co/qLAwfjahX9
Coronavirus updates: @WHO reports record one-day total for new cases, globally on Sunday Sept 13 with > 308,000 new cases. India, the United States and Brazil logged the largest number of new infections on Sunday. https://t.co/4h7BSIiIbc
— Carlos del Rio (@CarlosdelRio7) September 14, 2020
Explore the #1 ranked antimicrobial stewardship solution #KLASCategoryLeader https://t.co/f4i8WIBLR8 #BIK2020 #VigiLanzVigilant #pharmacy #antimicrobialstewardship pic.twitter.com/CBK9VIg9PA
— VigiLanz (@vigilanzcorp) September 14, 2020
New 3i Investigator Article Alert!! Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing. https://t.co/x0ol5aA28x #sciencetwitter #academictwitter #researchmatters
— UofU3i (@UofU3i) September 14, 2020
“We can’t forget that this, too, is a global health crisis,” @IDSAInfo president says of the growing threat of #antibioticresistance during the #COVID19 pandemic and beyond. https://t.co/dwOQRCZJMC
— Save Antibiotics (@saveantibiotics) September 14, 2020
Restrictions on movement have "dramatically decreased #influenza circulation this year", says @UNSW @KirbyInstitute infectious diseases expert, Prof Raina MacIntyre, on the new data. #Covid19Aus #Flu #COVID19 https://t.co/nBGQ1INSAc
— UNSW Medicine (@UNSWMedicine) September 14, 2020
Twitterless Drs. Jessie Seidelman & Dan Sexton had a commentary on bone & joint infections published to Clinical Infectious Diseases today. https://t.co/oddA3ae0iW pic.twitter.com/kQV2vpA2qS
— DICON (@DICON_duke) September 14, 2020
#AfricanSwineFever has been confirmed in Germany, Europe's largest pork producer, raising likelihood of widespread disruption in the market.#ASF, a disease transmitted to pigs & wild boar but not humans, has been a growing problem for neighboring Polandhttps://t.co/vWsUEJ5SvM
— Microbes&Infection (@MicrobesInfect) September 14, 2020
Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis | The Journal of Infectious Diseases | Oxford Academic https://t.co/JNpZWFbcfY
— Mary Walton (@mwaltonrx) September 14, 2020
"Roughly one of every five patients with bloodstream infections received discordant empirical antibiotic therapy, which was associated with increased odds of mortality"https://t.co/E7JFLtyz6d
— Dr. Alicia (@aliciad3) September 14, 2020
A Podcast recorded for @medscape on our #diagnosticstewardship approach to suspected CNS infections in children (available for CME/ABIM MOC credits):
— Kevin Messacar MD (@kmess44) September 14, 2020
Stories from the Field: Rapid Diagnostics for Meningitis and Encephalitis https://t.co/of9KBfTHtC
Great COVID treatment review by @mjwingler and David Cretella (@UMMCPharmacy preceptors) in the MS State Med Assoc Journal! https://t.co/Yze4wnOgwC
— Kayla Stover (@stoverkr) September 14, 2020
'Hard' outcomes (deaths & hospitalizations) show decreasing trends in SC, while cases have hit resistance to further declines. The 'minor' peak in the 7-d moving avg of cases @ Sep 7 reflects students returning to campus. % pos tests bounce b/w 10-20% 👇https://t.co/gypHNBgiqR pic.twitter.com/UzvQ1aRoRH
— Linda Kelemen, ScD (@lkelemen13) September 14, 2020
Lilly announced the results Monday from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases. https://t.co/fUG04qxB9T
— WISH-TV (@WISH_TV) September 14, 2020
The only question we need ask is, 'Was there ever a deadly virus.?' The answer is no.
— 🇬🇧 🏴 Joseph Collins #KBF (@Corky_Brexit) September 14, 2020
A new virus strain maybe but that is not unusual & they always go after the elderly with pre existing comorbidities.
The Govt & SAGE knew this prior to lockdown.https://t.co/nWOpDb4Xek
Diagnostic accuracy of nucleic acid amplification tests in detecting C. perfringens-associated diseases is relatively insufficient to replace traditional reference standards as a single diagnostic test. @JClinMicro #ASMClinMicro https://t.co/xva1GwFfOS pic.twitter.com/wyirjG69xZ
— ASM (@ASMicrobiology) September 14, 2020
SARS-CoV-2 transmission via speech-generated respiratory droplets - The Lancet Infectious Diseases https://t.co/xBDWEwuz2s #covid19 #coronavirus
— Coronavirus Long Haul Covid19 (@PandemicCovid20) September 14, 2020
Amazing and important table including comparison between shorter #antibiotics versus longer duration in #Antimicrobial_Stewardship 👌#AMR pic.twitter.com/llAeXSnP0Y
— Rasha Abdelsalam (@salam_rasha) September 14, 2020
Cases of #COVID19 are on the rise in Quebec. @CTVMontreal spoke with Dr. Matthew Oughton, Microbiologist in the Department of Infectious Diseases at the Jewish General Hospital @CIUSSS_COMTL to discuss what this rise in cases means for Quebecers & more.https://t.co/683b0QXzHZ
— CIUSSS Centre-Ouest (@CIUSSS_COMTL) September 14, 2020
Pathogens responsible for many infectious diseases are microbes and as such are the target of hygiene measures.#learning #innovation #research #goals #success #STEM #edtech #autism #books #science #skills #facts #kids #education #coronavirus #COVID19 https://t.co/fFXUX6pr5z
— Happiness Classroom (@Learnography) September 14, 2020
The presence of a single repetitive element in the centromeres of some Verticillium species coincides with increased centromere sizes and genome-wide repeat expansions and contributes to the diversity and evolution of Verticillium centromeres @mBioJournal https://t.co/SXcBl9ChFU pic.twitter.com/i8PnSXFkLT
— ASM (@ASMicrobiology) September 14, 2020
Curing COVID-19 - The Lancet Infectious Diseases https://t.co/AnywzSQsgy #covid19 #coronavirus
— Coronavirus Long Haul Covid19 (@PandemicCovid20) September 14, 2020
.@CDCgov expert says it’s "vitally important" to develop a new #antibiotic development pipeline, @axios reports. https://t.co/AXjpXvvxdN
— Save Antibiotics (@saveantibiotics) September 14, 2020
@Evotec and the French-based @BIOASTER Technological Research Institute today announced that they have entered into a partnership to advance research for infectious diseases | #researchneverstops #antimicrobialresistance #AMR | Press release https://t.co/SEquuY7qLo pic.twitter.com/L61lyIxGdb
— cyprotex (@cyprotex) September 14, 2020
Ho hum, just another major scandal:
— Tim Lahey (@TimLaheyMD) September 14, 2020
US president holds large indoor gathering in violation of state coronavirus protections
Related: attendees demonstrate confusion about state coronavirus protections https://t.co/ZkWQsppuGd pic.twitter.com/klTUUuIfsR
Dr. @zchagla, Associate Professor and infectious diseases specialist, et al. comment on four potential scenarios for the #COVID19 vaccine. @globeandmail 😷🦠https://t.co/2HxCf3xe0l https://t.co/jLtusV175o
— McMaster Dept. of Medicine (@MacDeptMed) September 14, 2020
How long do cold and #flu viruses stay alive after infected people cough or sneeze? https://t.co/NGrrlBvIZb pic.twitter.com/u0igoqIcCf
— Oscillococcinum USA (@OscilloUSA) September 14, 2020
Don’t miss @TheLancet journals’ session details & related content for #ECCVID. Sign up for Lancet Conference Alerts | Infectious Diseases today: https://t.co/3RCaLimKmK pic.twitter.com/slSvuBVrZJ
— The Lancet Global Health (@LancetGH) September 14, 2020
The anti-vaccine movement that first took hold in the U.S. and spread globally has undermined advances against #preventable infectious diseases such as #measles and #whooping cough. https://t.co/zLpTMRNpTP
— Master in Vaccinology and Drug Development (@InVaccinology) September 14, 2020
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.